Expanding RNAi to Kidneys, Lungs, and Spleen via Selective ORgan Targeting (SORT) siRNA Lipid Nanoparticles
Amogh Vaidya(The University of Texas Southwestern Medical Center), Daniel J. Siegwart(Southwestern Medical Center)
Cited by 65
Related Papers
Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR–Cas gene editing
|Nature Materials|2021|611
Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing
|Nature Communications|2020|575
Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery
|Nature Protocols|2022|499
Zwitterionic Phospholipidation of Cationic Polymers Facilitates Systemic mRNA Delivery to Spleen and Lymph Nodes
|Journal of the American Chemical Society|2021|161
A Systematic Study of Unsaturation in Lipid Nanoparticles Leads to Improved mRNA Transfection In Vivo
|Angewandte Chemie International Edition|2020|130